NewAmsterdam Pharma Co N.V.
NAMSW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $28.1M in total; no superinvestor holds it.
Other share classesNAMS
Q1 2023 vs. Q4 2022
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 22 | 19 | −3 |
| Shares | 1.93M | 1.57M | −363.1K (−18.8%) |
| Value | $1.91M | $4.12M | +$2.21M (+115.3%) |
New holders (2)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 37,000 | $68.5K | 0.03% |
| Clear Street LLC | 17,619 | $32.4K | 0.01% |
Sold out (5)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Castle Creek Arbitrage, LLC | 51,520 | $43.0K |
| DuPont Capital Management Corp | 8,333 | $6.67K |
| Wolverine Asset Management LLC | 1,462 | $1.27K |
| UBS Group AG | 1,076 | $936 |
| Alyeska Investment Group, L.P. | 285,105 | – |